Cost-Effectiveness Analysis: Status Quo

Background

Wancorp Ltd. has a company medical plan for its employees. Until now, this plan has not included any coverage related to breast cancer, but Wancorp now wants to address breast cancer in its 50-year-old female employees. Four options are being considered:
  1. Maintain the status quo and provide no coverage at no additional cost
  2. Offer breast cancer screening from age 50 to 65. This will catch some cancers earlier, and prevent some deaths, at some additional cost
  3. Offer high-dose chemotherapy with autologous bone marrow transplantation (HDC-ABMT) to women who develop metastatic breast cancer betewen age 50 and 65. This will prevent some deaths, at some additional cost
  4. Offer both screening and HDC-ABMT

In order to make the decision, Wancorp has come to you as an expert in cost-effectiveness. Thinking about the problem, you realize that you need the following background information to establish a baseline with which to compare the new options: